Information about Matsen Life Sciences
My details
*
*
*

Matsen Life Sciences (SRL)

BE 0782.905.509

Topmolen 122/A101, 1840 Londerzeel

Company information

Status
Active

Enterprise number

BE0782.905.509

VAT liability
Yes
Established
04-03-2022
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Medical laboratory and imaging activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Matsen Life Sciences

2024 2023 2022
Profit/Loss € -61,211 -335 % € 25,995 -50 % € 51,585
Equity € 21,368 -74 % € 82,579 46 % € 56,585
Gross margin € -51,295 -215 % € 44,776 -37 % € 70,561

Publications from Matsen Life Sciences

Date Publication
08-03-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Matsen Life Sciences?
The VAT number of Matsen Life Sciences is BE 0782.905.509.
Wat is the PEPPOL ID of Matsen Life Sciences?
There is no information available about the PEPPOL ID of Matsen Life Sciences or the company is not yet registered on the PEPPOL network.
When was Matsen Life Sciences founded?
Matsen Life Sciences was founded on 04-03-2022.
What is the address of Matsen Life Sciences?
The current registered office of Matsen Life Sciences is located at Topmolen 122/A101, 1840 Londerzeel.
When was the last time Matsen Life Sciences filed their annual financial statements?
The most recent financial statements of Matsen Life Sciences were filed on 16-07-2025.
How many employees does Matsen Life Sciences have?
There are currently no employees working at Matsen Life Sciences or no workforce information is available.
What is the annual turnover of Matsen Life Sciences?
At the time of its most recent financial statements, Matsen Life Sciences did not publish any turnover figures. Matsen Life Sciences reported a gross margin of -€51,295.36.

Sources